# Pathway Labs

> Publicly sourced profile assembled by Optimly, in the Optimly AI Brand Index. Last refreshed 2026-10-04.

- **Business Profile:** https://optimly.ai/brand/pathway-labs
- **Dataset:** https://optimly.ai/brand/pathway-labs.json
- **Markdown:** https://optimly.ai/brand/pathway-labs/llms.txt
- **Official website:** https://pathwaylabs.com
- **Slug:** pathway-labs
- **Categories:** ai-machine-learning, healthcare-it

## Overview

- **Tagline:** EchoNext turns the world's most common cardiac test (12-lead ECG) into an AI-driven biomarker without requiring new hardware or retraining staff, providing actionable insights for high-risk patients. It is supported by extensive peer-reviewed, prospectively validated research.
Source: Brand's website (https://pathwaylabs.com) · 2026-10-04

- **Description:** Pathway Labs offers EchoNext, an AI-powered platform that transforms standard 12-lead ECGs into a next-generation biomarker for early detection of structural heart disease. It aims to increase new clinically significant diagnoses and integrate seamlessly into existing healthcare workflows.
Source: Brand's website (https://pathwaylabs.com) · 2026-10-04

## Offerings

- **Core capabilities:**
  - EchoNext
  - an AI-powered platform that analyzes standard 12-lead ECGs to detect structural heart disease.
Source: Brand's website (https://pathwaylabs.com) · 2026-10-04

- **Pricing:** Not explicitly mentioned in the provided data.
Source: Brand's website (https://pathwaylabs.com) · 2026-10-04

## Audience

- **Target industry:** Health systems, hospitals, and cardiology teams seeking early and efficient detection of structural heart disease.
Source: Brand's website (https://pathwaylabs.com) · 2026-10-04

Page last updated 2026-10-17.